Literature DB >> 34381275

Evaluating Factors Associated With Blood Pressure Control in the Early Post-Kidney Transplant Period.

Matthew A Zuziela1, Jennifer Vidal1, John P Knorr1.   

Abstract

Background: Shortened allograft survival, and cardiovascular morbidity and mortality are consequences of inadequate control of hypertension for kidney transplant recipients (KTRs). Literature suggests the risk is multifactorial, although few studies have evaluated risk factors in relation to guideline recommended blood pressure (BP) goals in the early post-kidney transplant period. This study will elucidate factors associated with controlled BP in KTRs.
Methods: Adult KTRs who were transplanted between January 1, 2013, and October 31, 2018, were evaluated. Coprimary outcomes included the proportion of patients who had controlled BP at postoperative day (POD) 30 and identification of the covariates associated with controlled BP at POD 30. Additional outcomes included the proportion of patients who had controlled BP at POD 60 and 90; the difference in the average number of antihypertensive medications taken pretransplant vs POD 30, 60, and 90 for patients with controlled BP at POD 30; antihypertensive use rates pretransplant vs POD 30 and 90; and class of antihypertensive used pretransplant vs POD 30 and 90.
Results: At POD 30, 44% (100/226) of patients had controlled BP. The proportion of patients with controlled BP at POD 60 and 90 were 37% (82/220) and 40% (79/196), respectively. In bivariate analyses, lack of recipient hypertension (75% vs 42.5%, P = .04); fewer days on dialysis (1684 vs 2189 days, P = .005); absence of delayed graft function (51.2% vs 35.6%, P = .02); younger donor age (30 vs 40 years, P < .001); absence of donor hypertension (46.9% vs 29.3%, P = .004); and a lower median kidney donor profile index (29% vs 40%, P = .03) were associated with controlled BP at POD 30. In a multivariate analysis, donor age was independently associated with controlled BP at POD 30 (P = .03). Conclusions: This study suggests that younger donor age is associated with controlled BP, and conversely, older donor age is associated with uncontrolled BP in KTRs in the early post-kidney transplant period. Patients receiving a graft from older donors should have their BP closely monitored.
© The Author(s) 2020.

Entities:  

Keywords:  cardiovascular; clinical services; disease management; education; nephrology; pharmacists

Year:  2020        PMID: 34381275      PMCID: PMC8326856          DOI: 10.1177/0018578720906614

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  26 in total

1.  Spectrum of hypertension in post transplant.

Authors:  A Kaul; R K Sharma; A Gupta; U Singh
Journal:  J Assoc Physicians India       Date:  2010-04

2.  KDIGO clinical practice guideline for the care of kidney transplant recipients.

Authors: 
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

3.  Management of hypertension and factors affecting its control in Jordanian renal transplant recipients.

Authors:  Nailya Bulatova; Al-Motassem Yousef; Hisham Qusa; Ghada Al Khayat; Wadad Ailabouni; Ayman Wahbeh; Muhammad Al-Ulemat
Journal:  Int J Clin Pharm       Date:  2012-04-03

4.  Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology.

Authors:  F G Cosio; R P Pelletier; D D Sedmak; T E Pesavento; M L Henry; R M Ferguson
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

5.  Early initiation of angiotensin-converting enzyme inhibitors in postrenal transplant period: A study from a state-run tertiary care center.

Authors:  C G Sreeadhara; Raghavendra Narayanaswamy; Umesh Lingaraju; V Leelavathi; S M Shivaprasad
Journal:  Saudi J Kidney Dis Transpl       Date:  2018 May-Jun

Review 6.  Management of cardiovascular disease in renal transplant recipients.

Authors:  Anushree C Shirali; Margaret J Bia
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

7.  Significance of the donor age effect on kidney transplants.

Authors:  P I Terasaki; D W Gjertson; J M Cecka; S Takemoto; Y W Cho
Journal:  Clin Transplant       Date:  1997-10       Impact factor: 2.863

8.  Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.

Authors:  Barbara Suwelack; Viola Kobelt; Matthias Erfmann; Martin Hausberg; Ulf Gerhardt; Karl-Heinz Rahn; Helge Hohage
Journal:  Transpl Int       Date:  2003-02-20       Impact factor: 3.782

9.  Racial differences in renal allograft survival: the role of systemic hypertension.

Authors:  F G Cosio; J J Dillon; M E Falkenhain; R J Tesi; M L Henry; E A Elkhammas; E A Davies; G L Bumgardner; R M Ferguson
Journal:  Kidney Int       Date:  1995-04       Impact factor: 10.612

10.  Hypertension after kidney transplantation.

Authors:  Bertram L Kasiske; Shakeel Anjum; Rajiv Shah; Jeffrey Skogen; Chitra Kandaswamy; Barbara Danielson; Eileen A O'Shaughnessy; David C Dahl; John R Silkensen; Meena Sahadevan; Jon J Snyder
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.